Lawrence Erik Kurzius bought $549K of The Cooper Companies (COO)
Executed Sep 16, disclosed Sep 17, 1 day later.
Over the 21 trading sessions from the disclosed entry session (Sep 17), the stock returned +4.7% (delay-adjusted); from the execution session (Sep 16), +0.9%. Derived: entry at the session's open, exit at the close 20 sessions later.
Lawrence Erik Kurzius (Director) filed 9 Form 4 reports in the trailing twelve months (5 purchases, 4 sales), most often in McCormick & Company, Incorporated (MKC). Across 5 priced purchase filings, the average 21-session return was +1.9% from execution and +1.2% from disclosure (delay-adjusted; derived). The largest single filing was $10.8M of MKC (205,538 sh × $52.69, as filed), executed Aug 10.
Healthcare · The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→10,000 sh × $53.91
Exec Sep 14
Filed Sep 15 · 4:53 PM ET COOPURCHASE The Cooper Companies, Inc. $165K
2,000 sh × $82.50
Exec Dec 17 2025
Filed Dec 17 2025 · 5:06 PM ET COOPURCHASE The Cooper Companies, Inc. $137K
2,000 sh × $68.39
Exec Sep 29 2025
Filed Sep 29 2025 · 8:36 PM ET